Chemical Structure (Alogliptin 01)
Alogliptin And Pioglitazone Tablet, Film Coated
Product Images NDC 45802-402
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Alogliptin And Pioglitazone (NDC 45802-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Alogliptin 02)
Figure 1 (Alogliptin 03)
Figure 2 (Alogliptin 04)
This appears to be a list of drugs and their properties, including whether they are renally excreted or are inhibitors or substrates of certain enzymes. It also includes different dosages of Alogliptin and a recommendation. However, there is some garbled or unreadable text, so the full context and purpose of this information is not clear.*
Figure 3 (Alogliptin 05)
This appears to be a table showing the results of a study comparing the effectiveness of different doses of medications (Alogiptin and Piogitazone) versus a placebo in changing AIC levels in a population using statistical analysis. The table shows baseline data, different doses of the medications, and the percent change in AIC levels.*
Principal Display Panel (12.5 mg/15 mg Tablet Bottle Label)
Principal Display Panel (12.5 mg/30 mg Tablet Bottle Label)
Principal Display Panel (12.5 mg/45 mg Tablet Bottle Label)
This is a medication bottle with a warning not to accept if the seal is broken or missing. The recommended dosage is mentioned on the package insert. The medication contains 17mg alogliptin benzoate and 33.06mg pioglitazone hydrochloride. It should be stored in a tightly closed container at 25°C and protected from moisture and humidity. The medication is distributed by Perrigo and comes with a medication guide. There are 30 film-coated tablets in the bottle.*
Principal Display Panel (25 mg/15 mg Tablet Bottle Label)
This is a medication with dosage information and precautions. It contains Alogliptin benzoate and Pioglitazone hydrochloride equivalent to 45 mg of Poliazone. The medication should be stored at 25°C (77°F), the container should be tightly closed to protect it from moisture and humidity. It has 30 tablets in the package with usual dosages indicated in the package insert. Keep it out of the reach of children and do not accept the product if the seal over the bottle opening is broken or missing. It comes with a medication guide. The text also contains a NDC code and a distribution company based in Michigan, US.*
Principal Display Panel (25 mg/30 mg Tablet Bottle Label)
This is a medication package insert for a drug containing abogliptin benzoate and pioglitazone hydrochloride. It includes dosage instructions and storage recommendations, as well as cautionary statements to keep the medication out of reach of children and to check for a broken seal on the bottle. The medication is in tablet form and distributed by Perrigo out of Allegan, MI.*
Principal Display Panel (25 mg/45 mg Tablet Bottle Label)
This is a medication guide for tablets containing abogliptin benzoate and pioglitazone hydrochloride used to treat diabetes. It warns the reader not to accept the medication if the seal over the bottle opening is broken or missing and to keep it out of reach of children. The usual dosage instructions can be found in the package insert. The tablets should be stored at 25°C and protected from moisture and humidity. The medication is distributed by Perigo and is available in packs of 30 tablets.*
Alogliptin 12
This is a medication guide for a tablet containing alogliptin benzoate and pioglitazone hydrochloride used for diabetes treatment. The usual dosage is specified in the package insert, and the tablets should be stored at 25°C, protected from moisture and humidity. It is essential to keep the container tightly closed and out of reach of children. If the bottle's seal is broken or missing, do not accept it. The medicine is distributed by Perrigo and comes in 30 tablet packaging.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
